Facilitating treatment of HCV in primary care in regional Australia: closing the access gap

BACKGROUND: Australia has unrestricted access to direct-acting antivirals (DAA) for hepatitis C virus (HCV) treatment. In order to increase access to treatment, primary care providers are able to prescribe DAA after fibrosis assessment and specialist consultation. Transient elastography (TE) is reco...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Frontline Gastroenterol
Главные авторы: White, Lauren, Azzam, Ali, Burrage, Lauren, Orme, Clare, Kay, Barbara, Higgins, Sarah, Kaye, Simone, Sloss, Andrew, Broom, Jennifer, Weston, Nicola, Mitchell, Jonathan, O’Beirne, James
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2019
Предметы:
Liver
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583569/
https://ncbi.nlm.nih.gov/pubmed/31288252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2018-101049
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы